Aqua Medical has received investigational device exemption (IDE) from the FDA for its ablation device aimed at treating ...
Venclose Celebrates 2,000th Procedure with Next-Generation Endovenous Radiofrequency Ablation System
SAN JOSE, Calif. – March 19, 2018 – Venclose, Inc., a privately-held Silicon Valley medical technology company, today announced that more than 2,000 patients have been treated with the company’s ...
A non-surgical procedure called radiofrequency ablation can be highly effective in reducing or eliminating chronic back and joint pain in patients. The procedure can provide long-term relief by ...
Some 80,000 Americans will be diagnosed with a brain tumor this year according to the American Brain Tumor Association. Many of them will need major surgery and chemotherapy. Sixteen thousand of them ...
Radiofrequency ablation has been accepted as the most popular local ablative therapy for unresectable malignant hepatic tumors. For 9 years from April 1999, we performed 3000 radiofrequency ablation ...
Many people with arthritic knee pain turn to total knee replacements in hopes of alleviating the debilitating condition. Yet, about 15-30% of people who opt for the surgery continue to suffer from ...
A Dallas physician has performed a multiple cooled radiofrequency ablation of the sacroiliac joint using new equipment, marking the first such procedure to be performed in the state. During the ...
WILMINGTON, DE / ACCESSWIRE / August 9, 2022 / Transparency Market Research Inc. - A study by Transparency Market Research (TMR) expects the global radiofrequency ablation devices market to develop at ...
The National Institute for Clinical Excellence is examining percutaneous radiofrequency ablation of renal cancer and will publish guidance on its safety and efficacy to the NHS in England and Wales.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback